MacroGenics, Inc. (MGNX)
NASDAQ: MGNX · Real-Time Price · USD
3.010
-0.040 (-1.31%)
Apr 28, 2026, 4:00 PM EDT - Market closed

MacroGenics Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025 FY 2024 FY 2023 FY 2022 FY 2021 2020 - 2016
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 2020 - 2016
Net Income
-74.62-66.97-9.06-119.76-202.12
Upgrade
Depreciation & Amortization
7.177.549.6511.8711.26
Upgrade
Loss (Gain) From Sale of Assets
-0.01-36.310.11--
Upgrade
Loss (Gain) From Sale of Investments
-1.65-2.81-50.41.61
Upgrade
Stock-Based Compensation
14.2929.4418.3720.4423.13
Upgrade
Other Operating Activities
2.11-0.66-145.596.224.73
Upgrade
Change in Accounts Receivable
-9.066.0645.86-45.8412.7
Upgrade
Change in Inventory
-7.91-2.190.230.06-6.42
Upgrade
Change in Accounts Payable
-0.28-1.531.28-10.867.13
Upgrade
Change in Unearned Revenue
-5.4-9.4111.4348.829.26
Upgrade
Change in Other Net Operating Assets
-5.688.47-5.481.69-5.09
Upgrade
Operating Cash Flow
-81.04-68.37-78.21-86.96-143.83
Upgrade
Capital Expenditures
-1.91-3.71-1.76-3.62-6.2
Upgrade
Sale of Property, Plant & Equipment
0.010.160.06--
Upgrade
Investment in Securities
-112.19112.84-78.3874.34-30.41
Upgrade
Other Investing Activities
-40---
Upgrade
Investing Cash Flow
-114.1149.3-80.0870.72-36.61
Upgrade
Issuance of Common Stock
0.133.441.171.66122.78
Upgrade
Repurchase of Common Stock
-0.29-2.48-0.31--
Upgrade
Other Financing Activities
69.67-149.5--
Upgrade
Financing Cash Flow
69.510.96150.361.66122.78
Upgrade
Net Cash Flow
-125.6281.88-7.93-14.59-57.66
Upgrade
Free Cash Flow
-82.95-72.08-79.97-90.58-150.03
Upgrade
Free Cash Flow Margin
-55.49%-48.07%-136.12%-59.62%-193.72%
Upgrade
Free Cash Flow Per Share
-1.31-1.15-1.29-1.47-2.50
Upgrade
Cash Income Tax Paid
0.3----
Upgrade
Levered Free Cash Flow
-58.23-32.49-25.04-105.11-71.23
Upgrade
Unlevered Free Cash Flow
-52.91-31.79-24.15-105.11-71.23
Upgrade
Change in Working Capital
-28.331.3953.32-6.1317.57
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.